Not applicableUnknownNCT06187493What this trial is testingTreatment of Patients With Diabetic Kidney DiseaseWho this might be right forDiabetic Kidney Disease Assiut University 70
Post-approval studies (Phase 4)Looking for participantsNCT07143773What this trial is testingSGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant RecipientsWho this might be right forKidney Transplantation RecipientsSodium-Glucose Transporter 2 InhibitorsNon-Diabetic Patients+2 more Odense University Hospital 88
Testing effectiveness (Phase 2)Looking for participantsNCT06655480What this trial is testingTriple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEFWho this might be right forHFpEFLVDDMyocardial Fibrosis National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Not applicableStudy completedNCT05953701What this trial is testingSecondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient CharacteristicsWho this might be right forChronic Kidney Diseases AstraZeneca 800,211
Post-approval studies (Phase 4)Study completedNCT04196231What this trial is testingDurability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)Who this might be right forType 2 Diabetes University of Campania Luigi Vanvitelli 258
Post-approval studies (Phase 4)Not Yet RecruitingNCT06762223What this trial is testingHenagliflozin on Liver Fibrosis in Patients with MASLD and T2DMWho this might be right forMetabolic Dysfunction-associated Steatotic Liver DiseaseType 2 Diabetes Mellitus Xiqiao Zhou 190
Large-scale testing (Phase 3)Study completedNCT02773368What this trial is testingA Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 420
Post-approval studies (Phase 4)Looking for participantsNCT06625073What this trial is testingRandomized Trial of SGLT2i in Heart Transplant RecipientsWho this might be right forHeart TransplantCardiovascular DiseaseKidney Disease VA Office of Research and Development 200
Post-approval studies (Phase 4)Active Not RecruitingNCT06000462What this trial is testingThe Effect of Dapagliflozin on Weight Loss in Obese Adults Without DiabetesWho this might be right forObesityDapagliflozin Adverse ReactionWeight Loss+1 more Oman Ministry of Health 150
Post-approval studies (Phase 4)Study completedNCT03050229What this trial is testingSGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)Who this might be right forNocturnal HypertensionT2DM (Type 2 Diabetes Mellitus) Jichi Medical University 174
Large-scale testing (Phase 3)Active Not RecruitingNCT04333823What this trial is testingAdolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration TrialWho this might be right forDiabetes Mellitus, Type 1 The Hospital for Sick Children 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687212What this trial is testingRandomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEFWho this might be right forHeart Failure, Preserved Ejection Fraction The First Affiliated Hospital of Air Force Medicial University 162
Not applicableUnknownNCT06245980What this trial is testingRole of SGLT2I in Patients With Myocardial InfarctionWho this might be right forMyocardial InfarctionDiabetes Mellitus Dongying Zhang 1,200
Not applicableActive Not RecruitingNCT07471802What this trial is testingMonitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)Who this might be right forDiabete Type 2Heart FailureKidney Disease, Chronic+1 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 150
Large-scale testing (Phase 3)Looking for participantsNCT06030843What this trial is testingThe Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1Who this might be right forEmpagliflozin in Cardiorenal Syndrome Type 1 Chulalongkorn University 200
Very early researchLooking for participantsNCT07053293What this trial is testingSGLT2i, Hepatic Glucose Production, and SNSWho this might be right forType 2 Diabetes The University of Texas Health Science Center at San Antonio 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07488689What this trial is testingAssessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory DysfunctionWho this might be right forSeptic Shock University Hospital, Strasbourg, France 568
Testing effectiveness (Phase 2)Study completedNCT06393348What this trial is testingEfficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.Who this might be right forType 2 Diabetes Shandong Suncadia Medicine Co., Ltd. 155
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143What this trial is testingProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2Who this might be right forAcute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor Amsterdam UMC 784
Large-scale testing (Phase 3)UnknownNCT05605158What this trial is testingComparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisWho this might be right forNon Alcoholic Steatohepatitis Tanta University 56